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Introduction
Systemic lupus erythematosus (SLE) is a prototype auto-
immune disease. Infectious triggers, genetic background,
immunological abnormalities and environmental factors
are all supposed to interact in disease development.
Rare causes of monogenic SLE have been described,
(e.g. complement deficiencies, interferonopathies and
FasL deficiency) providing unique insights into funda-
mental mechanisms of immune tolerance.
Objectives
Our objective was to identify the cause of an autosomal
recessive form of SLE in an inbred family with three
affected siblings.
Methods
We investigated three siblings and used next generation
sequencing to identify mutations in the disease-associated
gene. We performed extensive biochemical, immunologi-
cal and functional assays to assess the impact of the identi-
fied mutations on B cell biology.
Results
Genetic mapping and targeted exome sequencing lead to
the identification of a homozygous mutation in PRKCD,
encoding protein kinase C delta (PKCδ). Mutation of
PRKCD resulted in reduced expression and activity of
encoded protein PKCδ. In mouse, PKCδ plays a crucial
role in the deletion of autoreactive B cells. As for mice
deficient in PKCδ, we demonstrated that B cells display a
resistance to calcium-dependent apoptosis and a higher
proliferation rate associated with an increase of immature
B cells in affected patients, and a developmental shift
toward an immature phenotype of naïve B cells.
Conclusion
Our findings indicate that PKCδ is crucial in regulating
B cell tolerance and preventing self-reactivity in humans.
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